Spatial Profiling and Digital Pathology

Reveal novel spatial relationships of the Tissue and Extracellular Vesicles (EVs) with multi-omic molecular signatures.

The AccuLift Spatial Profiler and the  Targeted  Extracellular Vesicle portfolios are unparalleled Spatial Biology profiling systems that harnesses the power of a cloud-based platform into one unique digital pathology ecosystem to study the complex tissue microenvironment.
 
As part of a complete spatial biology workflow that includes a novel suite of reagents and software, the AccuLift Spatial Profiler portfolio and Targeted EV portfolio  are designed to meet the needs of researchers and pathologists to transform Spatial Molecular Profiling and accelerate Precision Medicine.

Founded in 2018 as a spin-out from a technology transfer collaboration with George Masson University, the company now employs people from multiple disciplines including pathology, microfluids, molecular biology applications, informatics, engineering, electronics, manufacturing, and commercialization. The management team, led by CEO Alan Carpino, has a track record of delivering disruptive technologies to the market.


Targeted Bioscience, Inc

Org chart

Similar companies